MarketCap
Facebook
X
TelegramAnnual report 2024
added 03-04-2025
Nevro Corp. EV - Enterprise Value 2011-2026 | NVRO
Annual EV - Enterprise Value Nevro Corp.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 441 M | 783 M | 1.36 B | 2.52 B | 5.81 B | 4.38 B | 1.63 B | 2.52 B | 2.57 B | 1.61 B | 207 M | -4.44 M | -121 K | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5.81 B | -4.44 M | 1.83 B |
EV - Enterprise Value of other stocks in the Medical devices industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AdaptHealth Corp.
AHCO
|
3.89 B | $ 13.11 | 0.23 % | $ 1.77 B |  USA |
 |
BIOLASE
BIOL
|
26.8 M | - | -13.19 % | $ 166 K | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
76.6 M | - | - | $ 1.77 B | USA |
 |
Allied Healthcare Products
AHPI
|
696 K | - | 3.58 % | $ 2.21 M | USA |
 |
Lianluo Smart Limited
LLIT
|
655 M | - | 24.59 % | $ 44.8 M |  China |
 |
Eargo
EAR
|
-53 M | - | - | $ 10.2 M | USA |
 |
Apollo Endosurgery
APEN
|
423 M | - | - | $ 475 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-5.83 M | - | -5.86 % | $ 30.6 M | USA |
 |
Second Sight Medical Products
EYES
|
7.43 M | - | -0.97 % | $ 54.4 M | USA |
 |
Electromed
ELMD
|
170 M | $ 25.71 | 2.43 % | $ 217 M | USA |
 |
Avinger
AVGR
|
17.3 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
2.67 B | - | - | $ 3.31 B | USA |
 |
EDAP TMS S.A.
EDAP
|
139 M | $ 3.32 | 0.3 % | $ 124 M |  France |
 |
Aziyo Biologics
AZYO
|
-1.67 M | - | 1.37 % | $ 20.5 M | USA |
 |
BioSig Technologies
BSGM
|
33.9 M | - | 37.08 % | $ 85.7 M | USA |
 |
Conformis
CFMS
|
3.84 M | - | - | $ 16.4 M | USA |
 |
ClearPoint Neuro
CLPT
|
340 M | $ 11.18 | 8.12 % | $ 317 M | USA |
 |
Helius Medical Technologies
HSDT
|
3.7 M | $ 2.04 | 3.03 % | $ 1.24 M | USA |
 |
Cardiovascular Systems
CSII
|
595 M | - | 0.15 % | $ 844 M | USA |
 |
Cytosorbents Corporation
CTSO
|
66.9 M | $ 0.61 | -4.04 % | $ 38 M | USA |
 |
CryoLife, Inc.
CRY
|
70.4 M | - | -4.14 % | $ 702 M | USA |
 |
Inspire Medical Systems
INSP
|
1.78 B | $ 56.14 | 5.11 % | $ 1.65 B | USA |
 |
CHF Solutions, Inc.
CHFS
|
-7.7 M | - | 1.15 % | $ 34.5 M | USA |
 |
Invacare Corporation
IVC
|
-34.7 M | - | - | $ 24.7 M | USA |
 |
Soliton, Inc.
SOLY
|
-100 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
7.54 B | - | -1.98 % | $ 98.3 M | USA |
 |
IRIDEX Corporation
IRIX
|
34.8 M | $ 1.03 | - | $ 17.4 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
427 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Dynatronics Corporation
DYNT
|
13.8 M | - | 14.99 % | $ 929 K | USA |
 |
Misonix, Inc.
MSON
|
-1.79 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
639 M | - | - | $ 111 M |  Canada |
 |
LivaNova PLC
LIVN
|
4.58 B | $ 60.1 | 2.0 % | $ 3.28 B |  Britain |
 |
OrthoPediatrics Corp.
KIDS
|
579 M | $ 15.06 | 2.87 % | $ 353 M | USA |
 |
Butterfly Network
BFLY
|
765 M | $ 4.79 | -2.64 % | $ 1.01 B | USA |
 |
Intersect ENT, Inc.
XENT
|
1.02 B | - | - | $ 955 M | USA |
 |
GBS
GBS
|
6.89 M | - | -0.57 % | $ 7.12 M | USA |
 |
Globus Medical
GMED
|
12.7 B | $ 90.18 | 2.72 % | $ 12.2 B | USA |
 |
Delcath Systems
DCTH
|
295 M | $ 10.38 | 1.67 % | $ 372 M | USA |
 |
NanoVibronix
NAOV
|
3.4 M | - | - | $ 1.08 M | USA |
 |
CONMED Corporation
CNMD
|
2.57 B | $ 36.66 | 1.95 % | $ 1.14 B | USA |
 |
Integer Holdings Corporation
ITGR
|
4.62 B | $ 88.51 | 5.78 % | $ 3.07 B | USA |
 |
Edwards Lifesciences Corporation
EW
|
49.3 B | $ 83.5 | 2.81 % | $ 48.8 B | USA |
 |
LENSAR
LNSR
|
142 M | $ 5.23 | -2.97 % | $ 62.5 M | USA |
 |
Pulmonx Corporation
LUNG
|
78.3 M | $ 1.28 | 6.67 % | $ 52.1 M | USA |
 |
MiMedx Group
MDXG
|
699 M | $ 3.36 | 8.91 % | $ 497 M | USA |
 |
Myomo
MYO
|
47 M | $ 0.86 | 8.54 % | $ 36 M | USA |
 |
Cutera
CUTR
|
421 M | - | -10.19 % | $ 1.99 M | USA |
 |
NuVasive
NUVA
|
2.04 B | - | - | $ 2.07 B | USA |
 |
Natus Medical Incorporated
NTUS
|
863 M | - | 1.94 % | $ 1.05 B | USA |